SC 13D/A 1 0001.txt ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------------------- SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) INTEGRAMED AMERICA, INC. (Name of Issuer) Common Stock $.01 par value (Title of Class of Securities) ----------------------- 45810N 30 2 (Cusip Number) Morgan Stanley Dean Witter & Co. (Name of Persons Filing Statement) Peter Vogelsang Morgan Stanley Dean Witter & Co. 1221 Avenue of the Americas New York, New York 10020 Tel. No. 212-762-8422 with a copy to: John A. Bick Davis Polk & Wardwell 450 Lexington Avenue New York, New York 10017 Tel. No. 212-450-4350 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 26, 2001 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this statement because of Rule 13d-1(b)(3) or (4), check the following: [ ] Check the following box if a fee is being paid with this statement: [ ] ================================================================================ SCHEDULE 13D CUSIP No. 45810N 30 2 Page 2 of 14 Pages ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Morgan Stanley Dean Witter & Co. ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not applicable ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE ------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 NUMBER OF SHARES -------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY 0 EACH REPORTING -------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER 0 -------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) [ ] EXCLUDES CERTAIN SHARES* ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0 ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON CO ------------------------------------------------------------------------------- 2 SCHEDULE 13D CUSIP No. 45810N 30 2 Page 3 of 14 Pages ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Morgan Stanley Venture Capital III, Inc. ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE ------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 NUMBER OF SHARES -------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY 0 EACH REPORTING -------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER 0 -------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) [ ] EXCLUDES CERTAIN SHARES* ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0 ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON CO,IA ------------------------------------------------------------------------------- 3 SCHEDULE 13D CUSIP No. 45810N 30 2 Page 4 of 14 Pages ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Morgan Stanley Venture Partners III, L.L.C. ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE ------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 NUMBER OF SHARES -------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY 0 EACH REPORTING -------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER 0 -------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) [ ] EXCLUDES CERTAIN SHARES* ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0 ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON OO, IA ------------------------------------------------------------------------------- 4 SCHEDULE 13D CUSIP No. 45810N 30 2 Page 5 of 14 Pages ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Morgan Stanley Venture Partners III, L.P. ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE ------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 NUMBER OF SHARES -------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY 0 EACH REPORTING -------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER 0 -------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) [ ] EXCLUDES CERTAIN SHARES* ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0 ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN ------------------------------------------------------------------------------- 5 SCHEDULE 13D CUSIP No. 45810N 30 2 Page 6 of 14 Pages ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Morgan Stanley Venture Investors III, L.P. ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE ------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 NUMBER OF SHARES -------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY 0 EACH REPORTING -------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER 0 -------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) [ ] EXCLUDES CERTAIN SHARES* ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0 ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN ------------------------------------------------------------------------------- 6 SCHEDULE 13D CUSIP No. 45810N 30 2 Page 7 of 14 Pages ------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) The Morgan Stanley Venture Partners Entrepreneur Fund, L.P. ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable ------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] ------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE ------------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 NUMBER OF SHARES -------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER OWNED BY 0 EACH REPORTING -------------------------------------------- PERSON WITH 9 SOLE DISPOSITIVE POWER 0 -------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 ------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 ------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) [ ] EXCLUDES CERTAIN SHARES* ------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0 ------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON PN ------------------------------------------------------------------------------- 7 This Amendment to Schedule 13D is filed by the undersigned to amend and supplement the Schedule 13D, dated as of February 2, 1998 (the "Schedule 13D"), the latter of which was filed with respect to the purchase by the Funds of shares of common stock, $.01 par value per share (the "Common Stock"), and warrants to acquire shares of Common Stock (the "Warrants") of IntegraMed America, Inc., a Delaware corporation ("IntegraMed"). Capitalized terms used and not defined herein shall have the meanings set forth in the Schedule 13D. Items 1, 3, 4, 5, and 6. The responses set forth in Items 1, 4, and 5 of the Schedule 13D are hereby amended and supplemented by the following information: "On January 26, 2001, the Funds sold to IntegraMed the Warrants and all shares of Common Stock of IntegraMed beneficially owned by the Funds for $2,000,000. Accordingly, as of the date of this Amendment to Schedule 13D, the Reporting Persons no longer beneficially own any shares of capital stock of IntegraMed. This is the Reporting Persons' final amendment to the Schedule 13D and is an exit filing." Item 2 The response set forth in Item 2 of the Schedule 13D is hereby amended and restated by the following information: " (a) - (c) This Amendment to Schedule 13D is being filed jointly on behalf of the following persons (collectively, the "Reporting Persons"): (1) Morgan Stanley Dean Witter & Co., a Delaware corporation ("Morgan Stanley"), (2) Morgan Stanley Venture Capital III, Inc., a Delaware corporation ("MSVC III, Inc."), (3) Morgan Stanley Venture Partners III, L.L.C., a Delaware limited liability company ("MSVP III, L.L.C."), (4) Morgan Stanley Venture Partners III, L.P., a Delaware limited partnership, (5) Morgan Stanley Venture Investors III, L.P., a Delaware limited partnership, and (6) The Morgan Stanley Venture Partners Entrepreneur Fund, L.P., a Delaware limited partnership (Morgan Stanley Venture Partners III, L.P., Morgan Stanley Venture Investors III, L.P., and The Morgan Stanley Venture Partners Entrepreneur Fund, L.P. are collectively referred to as the "Funds"). The general partner of each of the Funds is MSVP III, L.L.C. The institutional managing member of MSVP III, L.L.C. is MSVC III, Inc., a wholly-owned subsidiary of Morgan Stanley. The address of the principal business and office of the Funds, MSVP III, L.L.C. and MSVC III, Inc. is 1221 Avenue of the Americas, New York, New York 10020-0001. The address of the principal business and principal office of Morgan Stanley is 1585 Broadway, New York, New York 10036. (d) - (e) During the past five (5) years, neither any of the Reporting Persons nor, to the best knowledge of any of the Reporting Persons, any of the other persons listed on Schedules A and B attached hereto has been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to United States federal or state securities laws or finding any violation with respect to such laws. (f) Not applicable." Item 7 This response set forth in Item 7 is hereby amended and supplemented by the following: 8 "Exhibit 4: Stock Purchase and Sale Agreement between IntegraMed America, Inc., and Morgan Stanley Venture Partners III, L.P., Morgan Stanley Venture Investors III, L.P., and The Morgan Stanley Venture Partners Entrepreneur Fund, L.P., dated as of January 26, 2001" "Exhibit 5: Joint filing agreement among the Reporting Persons, dated as of January 29, 2001" [This space intentionally left blank] 9 SIGNATURES After reasonable inquiry and to the best knowledge and belief of each of the undersigned, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: January 29, 2001 MORGAN STANLEY DEAN WITTER & CO. By: /s/ Peter Vogelsang ------------------------- Name: Peter Vogelsang Title: Authorized Signatory MORGAN STANLEY VENTURE CAPITAL III, INC. By: /s/ Debra Abramovitz ---------------------------- Name: Debra Abramovitz Title: Vice President MORGAN STANLEY VENTURE PARTNERS III, L.L.C. By: Morgan Stanley Venture Capital III, Inc., its Institutional Managing Member By: /s/ Debra Abramovitz ---------------------------- Name: Debra Abramovitz Title: Vice President MORGAN STANLEY VENTURE PARTNERS III, L.P. By: Morgan Stanley Venture Partners III, L.L.C., its General Partner By: Morgan Stanley Venture Capital III, Inc., its Institutional Managing Member By: /s/ Debra Abramovitz ---------------------------- Name: Debra Abramovitz Title: Vice President 10 MORGAN STANLEY VENTURE INVESTORS III, L.P. By: Morgan Stanley Venture Partners III, L.L.C. its General Partner By: Morgan Stanley Venture Capital III, Inc., its Institutional Managing Member By: /s/ Debra Abramovitz ---------------------------- Name: Debra Abramovitz Title: Vice President THE MORGAN STANLEY VENTURE PARTNERS ENTREPRENEUR FUND, L.P. By: Morgan Stanley Venture Partners III, L.L.C. its General Partner By: Morgan Stanley Venture Capital III, Inc., its Institutional Managing Member By: /s/ Debra Abramovitz ---------------------------- Name: Debra Abramovitz Title: Vice President 11 SCHEDULE A Executive Officers and Directors of Morgan Stanley Venture Capital III, Inc. The names of the Directors and the names and titles of the Executive Officers of Morgan Stanley Venture Capital III, Inc. ("MSVC III Inc.") are set forth below. The principal occupation for each of the persons listed below is Managing Director or other officer of Morgan Stanley & Co. Incorporated. If no address is given, the Director's or Executive Officer's business address is that of Morgan Stanley & Co. Incorporated at 1221 Avenue of the Americas, New York, New York 10020. Unless otherwise indicated, each title set forth opposite an individual's name refers to MSVC III Inc. and each individual is a United States citizen. Name, Business Address Executive Officer Title ---------------------- ----------------------- *Alan Goldberg Managing Director *Guy Louis deChazal Chairman and Chief Executive Director *John Ehrenkranz None *William James Harding Vice President *Robert John Loarie Vice President *Mian Fazle Husain Vice President *Scott Halsted Vice President Debra Eve Abramovitz Vice President and Treasurer Kenneth Clifford Vice President and Chief Financial Officer ----------------- * Director 12 SCHEDULE B Executive Officers and Directors of Morgan Stanley Dean Witter & Co. The names of the Directors and the names and titles of the Executive Officers of Morgan Stanley Dean Witter & Co. ("Morgan Stanley") and their business addresses and principal occupations are set forth below. If no address is given, the Director's or Executive Officer's business address is that of Morgan Stanley at 1585 Broadway, New York, New York 10036. Unless otherwise indicated, each occupation set forth opposite an individual's name refers to Morgan Stanley and each individual is a United States citizen. Name, Business Address Present Principal Occupation ---------------------- ---------------------------- * Phillip J. Purcell Chairman of the Board and Chief Executive Officer * John J. Mack + President and Chief Operating Officer * Robert P. Bauman Retired; former Chief Executive Officer of Smithkline Beecham plc * Edward A. Brennan Retired; former Chairman of the Board, President and Chief Executive Officer of Sears * C. Robert Kidder Chairman of the Board and Chief Executive Officer of Borden, Inc. * Charles F. Knight Chairman of Emerson Electric Co. * John W. Madigan Chairman of the Board, President and Chief Executive Officer of Tribune Company * Miles L. Marsh Chairman of the Board and Chief Executive Officer of Fort James Corporation * Michael A. Miles Special Limited Partner of Forstmann Little & Co. * Clarence B. Rogers, Jr. Retired; former Chairman of the Board and Chief Executive Officer of Equifax, Inc. * Laura D'Andrea Tyson Dean of the Walter A. Haas School of Business at the University of California, Berkeley Tarek F. Abdel-Meguid Head of Worldwide Investment Banking Stephen S. Crawford + Executive Vice President and Chief Strategic and Administrative Officer Zoe Cruz Head of Worldwide Fixed Income Division John P. Havens Head of Worldwide Institutional Equities Group 13 Donald G. Kempf, Jr. Executive Vice President, Chief Legal Officer and Secretary Mitchell M. Merin President and Chief Operating Officer of the Asset Management Group David W. Nelms President and Chief Operating Officer of Discover Financial Services Stephan F. Newhouse Co-President and Chief Operating Officer of Institutional Securities Group; Chairman, Morgan Stanley International Incorporated Vikram S. Pandit Co-President and Chief Operating Officer of Institutional Equities Group Joseph R. Perella Chairman of Institutional Securities Group John H. Schaefer President and Chief Operating Officer of Individual Investor Group Robert G. Scott + Executive Vice President and Chief Financial Officer -------------- * Director + On January 24, 2001, Morgan Stanley announced that its board of directors had accepted the resignation of John J. Mack, President and Chief Operating Officer, effective March 21, 2001. Robert G. Scott, Morgan Stanley's Chief Financial Officer, was named to succeed Mr. Mack. Stephen S. Crawford, Morgan Stanley's Chief Strategic and Administrative Officer, was named to succeed Mr. Scott. 14